Changeflow GovPing Pharma & Drug Safety EPO Patent EP2026029509A1: Expression Cassette
Routine Notice Added Final

EPO Patent EP2026029509A1: Expression Cassette

Favicon for changeflow.com EPO Patent Bulletin - Biotech (C12N)
Published
Detected
Email

Summary

The European Patent Office has published patent application EP2026029509A1 concerning an expression cassette comprising a Cyba-derived untranslated region and its use. The publication date is March 18, 2026, and the inventors have not yet filed their designation.

What changed

The European Patent Office (EPO) has published patent application EP2026029509A1, titled "EXPRESSION CASSETTE COMPRISING CYBA-DERIVED UNTRANSLATED REGION AND USE THEREOF." This publication, dated March 18, 2026, details a specific type of expression cassette relevant to biotechnology and pharmaceutical research.

This is a patent publication, not a regulatory rule or guidance. It does not impose new compliance obligations or deadlines on regulated entities. Companies operating in the biotechnology and pharmaceutical sectors may wish to review this patent for potential implications regarding intellectual property and research and development activities.

Archived snapshot

Mar 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

EXPRESSION CASSETTE COMPRISING CYBA-DERIVED UNTRANSLATED REGION AND USE THEREOF

Publication EP2026029509A1 Kind: A1 Mar 18, 2026

Inventors

The designation of the inventor has not yet been filed

IPC Classifications

C12N 15/67 20060101AFI20260208BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

EXPRESSION CASSETTE COMPRISING CYBA-DERIVED UNTRANSLATED REGION AND USE THEREOF

Get daily alerts for EPO Patent Bulletin - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP2026029509A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Biotechnology Research Drug Development
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Intellectual Property Biotechnology

Get alerts for this source

We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.